251 related articles for article (PubMed ID: 35565436)
1. A Disintegrin and Metalloproteinase (ADAM) Family-Novel Biomarkers of Selected Gastrointestinal (GI) Malignancies?
Łukaszewicz-Zając M; Pączek S; Mroczko B
Cancers (Basel); 2022 May; 14(9):. PubMed ID: 35565436
[TBL] [Abstract][Full Text] [Related]
2. A Disintegrin and Metalloproteinase (ADAM) Family: Their Significance in Malignant Tumors of the Central Nervous System (CNS).
Łukaszewicz-Zając M; Dulewicz M; Mroczko B
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638718
[TBL] [Abstract][Full Text] [Related]
3. Claudins-Promising Biomarkers for Selected Gastrointestinal (GI) Malignancies?
Łukaszewicz-Zając M; Mroczko B
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201579
[TBL] [Abstract][Full Text] [Related]
4. Insights Into the Regulation of Gynecological Inflammation-Mediated Malignancy by Metalloproteinases.
Begum Y; Pandit A; Swarnakar S
Front Cell Dev Biol; 2021; 9():780510. PubMed ID: 34912809
[TBL] [Abstract][Full Text] [Related]
5. A Disintegrin and Metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) family in vascular biology and disease.
Zhong S; Khalil RA
Biochem Pharmacol; 2019 Jun; 164():188-204. PubMed ID: 30905657
[TBL] [Abstract][Full Text] [Related]
6. The Role of Selected Serpins in Gastrointestinal (GI) Malignancies.
Pączek S; Mroczko B
J Clin Med; 2022 Oct; 11(20):. PubMed ID: 36294546
[TBL] [Abstract][Full Text] [Related]
7. ADAM8 in invasive cancers: links to tumor progression, metastasis, and chemoresistance.
Conrad C; Benzel J; Dorzweiler K; Cook L; Schlomann U; Zarbock A; Slater EP; Nimsky C; Bartsch JW
Clin Sci (Lond); 2019 Jan; 133(1):83-99. PubMed ID: 30635388
[TBL] [Abstract][Full Text] [Related]
8. Effects of culture conditions and exposure to catabolic stimulators (IL-1 and retinoic acid) on the expression of matrix metalloproteinases (MMPs) and disintegrin metalloproteinases (ADAMs) by articular cartilage chondrocytes.
Flannery CR; Little CB; Caterson B; Hughes CE
Matrix Biol; 1999 Jun; 18(3):225-37. PubMed ID: 10429942
[TBL] [Abstract][Full Text] [Related]
9. A dual inhibitor of matrix metalloproteinases and a disintegrin and metalloproteinases, [¹⁸F]FB-ML5, as a molecular probe for non-invasive MMP/ADAM-targeted imaging.
Matusiak N; Castelli R; Tuin AW; Overkleeft HS; Wisastra R; Dekker FJ; Prély LM; Bischoff R; van Waarde A; Dierckx RA; Elsinga PH
Bioorg Med Chem; 2015 Jan; 23(1):192-202. PubMed ID: 25438884
[TBL] [Abstract][Full Text] [Related]
10. Hepatic expression of A disintegrin and metalloproteinase (ADAM) and ADAMs with thrombospondin motives (ADAM-TS) enzymes in patients with chronic liver diseases.
Schwettmann L; Wehmeier M; Jokovic D; Aleksandrova K; Brand K; Manns MP; Lichtinghagen R; Bahr MJ
J Hepatol; 2008 Aug; 49(2):243-50. PubMed ID: 18490073
[TBL] [Abstract][Full Text] [Related]
11. Matrix Metalloproteinases: How Much Can They Do?
Ågren MS; Auf dem Keller U
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290531
[TBL] [Abstract][Full Text] [Related]
12. Role of ADAMs in cancer formation and progression.
Duffy MJ; McKiernan E; O'Donovan N; McGowan PM
Clin Cancer Res; 2009 Feb; 15(4):1140-4. PubMed ID: 19228719
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases (MMPs) in health and disease: an overview.
Malemud CJ
Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
[TBL] [Abstract][Full Text] [Related]
14. Differential expressions of matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs and their endogenous inhibitors among histologic subtypes of lung cancers.
Hida Y; Hamada J
Anticancer Agents Med Chem; 2012 Sep; 12(7):744-52. PubMed ID: 22292754
[TBL] [Abstract][Full Text] [Related]
15. Role of Some microRNA/ADAM Proteins Axes in Gastrointestinal Cancers as a Novel Biomarkers and Potential Therapeutic Targets-A Review.
Kalita A; Sikora-Skrabaka M; Nowakowska-Zajdel E
Curr Issues Mol Biol; 2023 Apr; 45(4):2917-2936. PubMed ID: 37185715
[TBL] [Abstract][Full Text] [Related]
16. ADAM protein family - its role in tumorigenesis, mechanisms of chemoresistance and potential as diagnostic and prognostic factors.
Zadka L; Kulus MJ; Piatek K
Neoplasma; 2018 Nov; 65(6):823-839. PubMed ID: 30334448
[TBL] [Abstract][Full Text] [Related]
17. ADAM-family metalloproteinases in lung inflammation: potential therapeutic targets.
Dreymueller D; Uhlig S; Ludwig A
Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(4):L325-43. PubMed ID: 25480335
[TBL] [Abstract][Full Text] [Related]
18. Expression and Function of a Disintegrin and Metalloproteinases in Cancer-Associated Fibroblasts of Colorectal Cancer.
Mochizuki S; Ao T; Sugiura T; Yonemura K; Shiraishi T; Kajiwara Y; Okamoto K; Shinto E; Okada Y; Ueno H
Digestion; 2020; 101(1):18-24. PubMed ID: 31722362
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of MMPs and ADAM/ADAMTS.
Malemud CJ
Biochem Pharmacol; 2019 Jul; 165():33-40. PubMed ID: 30826330
[TBL] [Abstract][Full Text] [Related]
20. Role of ADAM-9 disintegrin-cysteine-rich domains in human keratinocyte migration.
Zigrino P; Steiger J; Fox JW; Löffek S; Schild A; Nischt R; Mauch C
J Biol Chem; 2007 Oct; 282(42):30785-93. PubMed ID: 17704059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
